Procter & Gamble Health Limited engages in the manufacture and marketing of pharmaceuticals and chemical products in India and internationally. The company provides over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Cosome, Polybion, Neurobion, Evion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. The company was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India BV.
Stock data | 2023 | Change |
---|---|---|
Price | $60.94 | N/A |
Market Cap | $1.01B | N/A |
Shares Outstanding | 16.60M | 0.01% |
Employees | 1.41K | N/A |
Shareholder Equity | 7.51B | 21.80% |
Valuation | 2023 | Change |
---|---|---|
P/E Ratio | 0.44 | N/A |
P/S Ratio | 6.89 | N/A |
P/B Ratio | 0.13 | N/A |
Growth | 2023 | Change |
---|---|---|
Return on Equity | 0.0037 | N/A |
Earnings | 2023 | Change |
---|---|---|
Revenue | $146.92M | N/A |
Earnings | $27.42M | N/A |
EPS | 138.23 | N/A |
Earnings Yield | 2.27 | N/A |
Gross Margin | 0.7057 | N/A |
Operating Margin | 0.2406 | N/A |
Net income margin | 0.1866 | N/A |
Financial Strength | 2023 | Change |
---|---|---|
Total Assets | $131.58M | N/A |
Total Debt | $1.43M | N/A |
Cash on Hand | $54.10M | N/A |
Debt to Equity | 0.0056 | 3.74% |
Cash to Debt | $37.73 | -67.84% |
Current Ratio | $2.62 | 0.68% |